Evidence map›Paper›PMID 35230690›Full record

ArticleAdvances in experimental medicine and biology2022

Network Approaches for Precision Oncology.

Shraddha Pai

Abstract read
PubMed Publisher
In one paragraph

Article in Advances in experimental medicine and biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Shraddha PaiOntario Institute for Cancer Research, University of Toronto, Toronto, ON, Canada. shraddha.pai@utoronto.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The growth of multi-omic tumour profile datasets along with knowledge of genome regulatory networks has created an unprecedented opportunity to advance precision oncology. Achieving this goal requires computational methods that can make sense of and combine heterogeneous data sources. Interpretability and integration of prior knowledge is of particular relevance for genomic models to minimize ungeneralizable models, promote rational treatment design, and make use of sparse genetic mutation data. While networks have long been used to capture genomic interactions at the levels of genes, proteins, and pathways, the use of networks in precision oncology is relatively new. In this chapter, I provide an introduction to network-based approaches used to integrate multi-modal data sources for patient stratification and patient classification. There is a particular emphasis on methods using patient similarity networks (PSNs) as part of the design. I separately discuss strategies for inferring driver mutations from individual patient mutation data. Finally, I discuss challenges and opportunities the field will need to overcome to achieve its full potential, with an outlook towards a clinic of the future.

Indexed as

NeoplasmsGenomicsHumansMedical OncologyPrecision MedicineProteinsProteinsClassificationClusteringGene interaction networksLabel propagationMachine learningNetworkPathwaysPatient similarity networkSupervised learningUnsupervised learning

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.